Modern Methods of Diagnostics and Treatment of Neurodegenerative Diseases and Depression

This paper discusses the promising areas of research into machine learning applications for the prevention and correction of neurodegenerative and depressive disorders. These two groups of disorders are among the leading causes of decline in the quality of life in the world when estimated using disability-adjusted years. Despite decades of research, the development of new approaches for the assessment (especially pre-clinical) and correction of neurodegenerative diseases and depressive disorders remains among the priority areas of research in neurophysiology, psychology, genetics, and interdisciplinary medicine. Contemporary machine learning technologies and medical data infrastructure create new research opportunities. However, reaching a consensus on the application of new machine learning methods and their integration with the existing standards of care and assessment is still a challenge to overcome before the innovations could be widely introduced to clinics. The research on the development of clinical predictions and classification algorithms contributes towards creating a unified approach to the use of growing clinical data. This unified approach should integrate the requirements of medical professionals, researchers, and governmental regulators. In the current paper, the current state of research into neurodegenerative and depressive disorders is presented.

Deep Learning with Neuroimaging and Genomics in Alzheimer's Disease

A growing body of evidence currently proposes that deep learning approaches can serve as an essential cornerstone for the diagnosis and prediction of Alzheimer's disease (AD). In light of the latest advancements in neuroimaging and genomics, numerous deep learning models are being exploited to distinguish AD from normal controls and/or to distinguish AD from mild cognitive impairment in recent research studies. In this review, we focus on the latest developments for AD prediction using deep learning techniques in cooperation with the principles of neuroimaging and genomics. First, we narrate various investigations that make use of deep learning algorithms to establish AD prediction using genomics or neuroimaging data. Particularly, we delineate relevant integrative neuroimaging genomics investigations that leverage deep learning methods to forecast AD on the basis of incorporating both neuroimaging and genomics data. Moreover, we outline the limitations as regards to the recent AD investigations of deep learning with neuroimaging and genomics. Finally, we depict a discussion of challenges and directions for future research. The main novelty of this work is that we summarize the major points of these investigations and scrutinize the similarities and differences among these investigations.

Vocal Feature Extraction-Based Artificial Intelligent Model for Parkinson's Disease Detection

As a neurodegenerative disorder, Parkinson’s disease (PD) affects the nerve cells of the human brain. Early detection and treatment can help to relieve the symptoms of PD. Recent PD studies have extracted the features from vocal disorders as a harbinger for PD detection, as patients face vocal changes and impairments at the early stages of PD. In this study, two hybrid models based on a Support Vector Machine (SVM) integrating with a Principal Component Analysis (PCA) and a Sparse Autoencoder (SAE) are proposed to detect PD patients based on their vocal features. The first model extracted and reduced the principal components of vocal features based on the explained variance of each feature using PCA. For the first time, the second model used a novel Deep Neural Network (DNN) of an SAE, consisting of multiple hidden layers with L1 regularization to compress the vocal features into lower-dimensional latent space. In both models, reduced features were fed into the SVM as inputs, which performed classification by learning hyperplanes, along with projecting the data into a higher dimension. An F1-score, a Mathews Correlation Coefficient (MCC), and a Precision-Recall curve were used, along with accuracy to evaluate the proposed models due to highly imbalanced data. With its highest accuracy of 0.935, F1-score of 0.951, and MCC value of 0.788, the probing results show that the proposed model of the SAE-SVM surpassed not only the former model of the PCA-SVM and other standard models including Multilayer Perceptron (MLP), Extreme Gradient Boosting (XGBoost), K-Nearest Neighbor (KNN), and Random Forest (RF), but also surpassed two recent studies using the same dataset. Oversampling and balancing the dataset with SMOTE boosted the performance of the models.

Machine Learning for Predictive Modelling of Ambulance Calls

A novel machine learning approach is presented in this paper, based on extracting latent information and using it to assist decision making on ambulance attendance and conveyance to a hospital. The approach includes two steps: in the first, a forward model analyzes the clinical and, possibly, non-clinical factors (explanatory variables), predicting whether positive decisions (response variables) should be given to the ambulance call, or not; in the second, a backward model analyzes the latent variables extracted from the forward model to infer the decision making procedure. The forward model is implemented through a machine, or deep learning technique, whilst the backward model is implemented through unsupervised learning. An experimental study is presented, which illustrates the obtained results, by investigating emergency ambulance calls to people in nursing and residential care homes, over a one-year period, using an anonymized data set provided by East Midlands Ambulance Service in United Kingdom.

Alzheimer’s Disease Early Detection Using a Low Cost Three-Dimensional Densenet-121 Architecture

The objective of this work is to detect Alzheimer’s disease using Magnetic Resonance Imaging. For this, we use a three-dimensional densenet-121 architecture. With the use of only freely available tools, we obtain good results: a deep neural network showing metrics of 87% accuracy, 87% sensitivity (micro-average), 88% specificity (micro-average), and 92% AUROC (micro-average) for the task of classifying five different classes (disease stages). The use of tools available for free means that this work can be replicated in developing countries.